press releases

Celgene Launches Celgene Cancer Care Links TM to Support Cancer Healthcare Capacity Building in Resource-Constrained Countries

Grant Program Will Help Fund Cancer Care Capability, Delivery and Access Programs 

SUMMIT, NJ, December 5, 2017 – Celgene Corporation (NASDAQ:CELG) today announced the launch of Celgene Cancer Care Links, a new grant program designed to support cancer healthcare capacity building in resource-constrained countries around the world. As part of this program, Celgene will collaborate with medical centers focused on enhancing patient care and building sustainable cancer care systems in resourceconstrained countries. Funding will be provided to approved programs in 2018.
Read More

22 Biopharma Companies Partner and Launch First-of-its-kind Global Initiative to Address Rise of Non-Communicable Diseases

At the 2017 World Economic Forum in Davos, Switzerland, twenty-two leading biopharmaceutical companies launched Access Accelerated, a global initiative to advance access to non-communicable disease (NCD) prevention and care in low and middle income countries.

First Comprehensive Pediatric Hematology-Oncology Initiative Launched in Africa

  • Government of Botswana announces new public-private partnership to treat children with cancer and blood disorders
  • The $100 million initiative to create a pediatric hematology-oncology treatment network and care infrastructure is supported by $50 million donation from the Bristol-Myers Squibb Foundation and matched by $50 million in additional philanthropy
  • Partnership includes Texas Children’s Cancer and Hematology Centers, Baylor College of Medicine International Pediatric AIDS Initiative at Texas Children’s Hospital and the Governments of Botswana, Uganda and Malawi